Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Obesity is associated with a state of chronic, low-grade inflammation characterized by abnormal cytokine production and macrophage infiltration into adipose tissue, which may contribute to the development of insulin resistance. During immune responses, tissue infiltration by macrophages is dependent on the expression of osteopontin, an extracellular matrix protein and proinflammatory cytokine that promotes monocyte chemotaxis and cell motility. In the present study, we used a murine model of diet-induced obesity to examine the role of osteopontin in the accumulation of adipose tissue macrophages and the development of insulin resistance during obesity. Mice exposed to a high-fat diet exhibited increased plasma osteopontin levels, with elevated expression in macrophages recruited into adipose tissue. Obese mice lacking osteopontin displayed improved insulin sensitivity in the absence of an effect on diet-induced obesity, body composition, or energy expenditure. These mice further demonstrated decreased macrophage infiltration into adipose tissue, which may reflect both impaired macrophage motility and attenuated monocyte recruitment by stromal vascular cells. Finally, obese osteopontin-deficient mice exhibited decreased markers of inflammation, both in adipose tissue and systemically. Taken together, these results suggest that osteopontin may play a key role in linking obesity to the development of insulin resistance by promoting inflammation and the accumulation of macrophages in adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, the expression of osteopontin is elevated in obese adipose tissue (124)”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
In the citing paper
“and osteopontin-KO mice have reduced ATM content after HFD feeding and are protected against HFDinduced insulin resistance (124).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
In the citing paper
“and osteopontin-KO mice have reduced ATM content after HFD feeding and are protected against HFDinduced insulin resistance (124).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“As the majority of studies analyzing ATM content in murine models have used an antibody against the F4/80 antigen (3, 19), we further sought to corroborate these observations using staining for F4/80.”
BackgroundResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A host of adipose tissue–generated adipokines and cytokines have been identified that have emerged as an important source of systemic inflammation in obesity (2).”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 4×
“Based on the strong recent evidence that ATMs are both necessary and sufficient for the development of obesity-associated insulin resistance (4, 19, 43), the observed decrease in ATM content in obese OPN –/– mice provides a likely mechanism for the increased insulin sensitivity in these mice.”
BackgroundInfluentialAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
Research works printed but not linked: 1
- Zohar, R., et al. 2000. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell. Physiol. 184:118-130. · DOI · Paper page
Cited by
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Macrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
“For example, osteopontin — a secreted matrix glycoprotein that acts as a pro-inflammatory cytokine — promotes adipose tissue inflammation, insulin resistance and hepatic steatosi”
BackgroundInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
“These effects include the up- or down-regulation of the synthesis of resistin((138)), leptin, adiponectin((139)), lipocalin 2((140)), osteopontin((141)), and of insulin itself.”
Autophagy—a key player in cellular and body metabolism
Kim, K. H., & Lee, M.-S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.35 · Cited by 963
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Scott, R. A., Lagou, V., Welch, R. P., Wheeler, E., Montasser, M. E., Luan, J., Mägi, R., Strawbridge, R. J., Rehnberg, E., Gustafsson, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2385 · Cited by 828
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804
“…obesityinduced insulin resistance (Ellacott et al., 2007; Kanda et al., 2006; Lesniewski et al., 2007; Nara et al., 2007; Neels and Olefsky, 2006; Nomiyama et al., 2007; Weisberg et al., 2006), while an increase in ATMs is associated with a further deterioration of insulin sensitivity (Hirasaka…”
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
“(104) demonstrated that mice after a high-fat diet exhibited increased circulating OPN levels.”
BackgroundAdipocytokines and the Metabolic Complications of Obesity
Rasouli, N., & Kern, P. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1613 · Cited by 743
Lee, B.-C., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.017 · Cited by 695
Local Proliferation of Macrophages Contributes to Obesity-Associated Adipose Tissue Inflammation
Amano, S. U., Cohen, J. L., Vangala, P., Tencerova, M., Nicoloro, S. M., Yawe, J. C., Shen, Y., Czech, M. P., & Aouadi, M. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.017 · Cited by 613
“, 2013), osteopontin (OPN) (Nomiyama et al., 2007), and monocyte chemotactic protein (also referred to as chemokine [C-C motif] ligand 2 [CCL2/MCP-1]) (Kanda et al.”
InfluentialThe multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction
Choi, M.-C., Jo, J., Park, J., Kang, H. K., & Park, Y. (2019) · Cells · doi:10.3390/cells8070734 · Cited by 531
Immune Regulation of Metabolic Homeostasis in Health and Disease
Brestoff, J. R., & Artis, D. (2015) · Cell · doi:10.1016/j.cell.2015.02.022 · Cited by 497
Adipose tissue macrophages: their role in adipose tissue remodeling
Suganami, T., & Ogawa, Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0210072 · Cited by 445
“In addition to the MCP-1/CCR2 pathway, there are several reports suggesting the potential involvement of other chemotactic factors in obesity-induced macrophage infiltration [19, 20].”
BackgroundZhuang, G., Meng, C., Guo, X., Cheruku, P. S., Shi, L., Xu, H., Li, H., Wang, G., Evans, A. R., Safe, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.087817 · Cited by 428
Rogers, N. H., Perfield, J. W., Strissel, K. J., Obin, M. S., & Greenberg, A. S. (2009) · Endocrinology · doi:10.1210/en.2008-1405 · Cited by 418
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes
Kahles, F., Findeisen, H. M., & Bruemmer, D. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.004 · Cited by 408
“Analysis of adipose tissue cellular fractions revealed that the main source of OPN in human and murine genetic and diet-induced obesity are adipose tissue macrophages (ATM) [29,85].”
InfluentialSelf-citationNilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., Poulsen, P., Ribel-Madsen, R., Pedersen, N. L., Almgren, P., et al. (2014) · Diabetes · doi:10.2337/db13-1459 · Cited by 391
Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170040 · Cited by 373
Impaired Preadipocyte Differentiation in Human Abdominal Obesity
Isakson, P., Hammarstedt, A., Gustafson, B., & Smith, U. (2009) · Diabetes · doi:10.2337/db08-1770 · Cited by 369
“An additional possibility that needs to be considered is that there is a slow, continuous turnover of adipose cells ( 10% per year) (12) and that this depletes the number of available preadipocytes in the adipose tissue in obesity.”
BackgroundExtracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases
Ruiz-Ojeda, F. J., Méndez-Gutiérrez, A., Aguilera, C. M., & Plaza-Díaz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194888 · Cited by 301
Pietiläinen, K. H., Naukkarinen, J., Rissanen, A., Saharinen, J., Ellonen, P., Keränen, H., Suomalainen, A., Götz, A., Suortti, T., Yki-Järvinen, H., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050051 · Cited by 303
“obesity) that for the first time linked SPP1 to obesity and insulin resistance [49].”
BackgroundRodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 282
Identification of an Adipogenic Niche for Adipose Tissue Remodeling and Restoration
Lee, Y.-H., Petkova, A. P., & Granneman, J. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.003 · Cited by 279
“This recruitment is associated with systemic inflammation and insulin resistance (Chapman et al., 2010; Nomiyama et al., 2007), which are largely corrected by genetic deletion of Spp1.”
Obesity accelerates T cell senescence in murine visceral adipose tissue
Shirakawa, K., Yan, X., Shinmura, K., Endo, J., Kataoka, M., Katsumata, Y., Yamamoto, T., Anzai, A., Isobe, S., Yoshida, N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88606 · Cited by 271
FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages
Fan, W., Morinaga, H., Kim, J. J., Bae, E., Spann, N. J., Heinz, S., Glass, C. K., & Olefsky, J. M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.268 · Cited by 258
“…humans and rodents, adipose tissue macrophages (ATMs) accumulate in adipose tissue (AT) with increasing body weight, and ATMs are a significant contributor to inflammation and insulin resistance in obesity (Kanda et al, 2006; Weisberg et al, 2006; Nomiyama et al, 2007; de Luca and Olefsky, 2008).”
BackgroundThe membrane receptor CD44: novel insights into metabolism
Weng, X., Maxwell-Warburton, S., Hasib, A., Ma, L., & Kang, L. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.02.002 · Cited by 254
Daniele, G., Guardado Mendoza, R., Winnier, D., Fiorentino, T. V., Pengou, Z., Cornell, J., Andreozzi, F., Jenkinson, C., Cersosimo, E., Federici, M., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-013-0543-1 · Cited by 243
Defining macrophage phenotype and function in adipose tissue
Dalmas, E., Clément, K., & Guerre-Millo, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.008 · Cited by 245
Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 240
Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice
Li, P., Lu, M., Nguyen, M. T. A., Bae, E. J., Chapman, J., Feng, D., Hawkins, M., Pessin, J. E., Sears, D. D., Nguyen, A.-K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100263 · Cited by 237
Adipose extracellular matrix remodelling in obesity and insulin resistance
Lin, D., Chun, T.-H., & Kang, L. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.005 · Cited by 231
“OPN is highly expressed in adipose tissue macrophages [17].”
Deveaux, V., Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J. T.-V., Belot, M. P., Zimmer, A., Even, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005844 · Cited by 227
“including MCP-1, TNFa and osteopontin, that promote recruitment of proinflammatory macrophages and further amplification of local inflammation [4–9].”
BackgroundMatricellular proteins: from homeostasis to inflammation, cancer, and metastasis
Chiodoni, C., Colombo, M. P., & Sangaletti, S. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9221-8 · Cited by 221
Recent advances in nonalcoholic fatty liver disease
Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 219
Osteopontin Takes Center Stage in Chronic Liver Disease
Song, Z., Chen, W., Athavale, D., Ge, X., Desert, R., Das, S., Han, H., & Nieto, N. (2021) · Hepatology · doi:10.1002/hep.31582 · Cited by 213
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
“Subsequently, the contributions of chemokines other than the CCL family, such as CXCL14 (42) or other factors including osteopontin (43), angiopoietin-like protein 2 (Angptl2) (44), serum amyloid A (45), and dietary cholesterol (46), to the accumulation of macrophages in adipose tissue have been demonstrated.”
BackgroundArchitecture and the extracellular matrix: the still unappreciated components of the adipose tissue
Divoux, A., & Clément, K. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00811.x · Cited by 207
“Mice exposed to a high-fat diet exhibit increased plasma osteopontin levels with elevated expression in AT (18), suggesting a relationship between this ECM component and inflammation in obese AT.”
BackgroundBeyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L., et al. (2010) · Diabetes · doi:10.2337/db09-0404 · Cited by 200
“Other than in genetic OPN deficiency (26), glucose tolerance was apparently not affected by short-term OPN neutralization.”
BackgroundInfluentialJiao, P., Ma, J., Feng, B., Zhang, H., Alan‐Diehl, J., Eugene‐Chin, Y., Yan, W., & Xu, H. (2011) · Obesity · doi:10.1038/oby.2010.200 · Cited by 198
Kodama, K., Horikoshi, M., Toda, K., Yamada, S., Hara, K., Irie, J., Sirota, M., Morgan, A. A., Chen, R., Ohtsu, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114513109 · Cited by 171
“These analysis results led us to the speculation that our top-most candidate gene, CD44, encoding an immunecell surface receptor, may be implicated in adipose tissue inflammation causing insulin resistance in obesity, given the fact that the CD44 receptor is known to regulate immune-cell migration and activation and i…”
BackgroundResultJetten, A. M., Kang, H. S., & Takeda, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00001 · Cited by 169
“CD44 and Opn null mice are protected against the development of HFD-induced hepatosteatosis, WAT-associated inflammation, and insulin resistance (Nomiyama et al., 2007; Bertola et al., 2009; Kiefer et al., 2011; Kodama et al., 2012).”
BackgroundKui Tan, T., Zheng, G., Hsu, T.-T., Ra Lee, S., Zhang, J., Zhao, Y., Tian, X., Wang, Y., Min Wang, Y., Cao, Q., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.3 · Cited by 162
Self-citationKiefer, F. W., Zeyda, M., Todoric, J., Huber, J., Geyeregger, R., Weichhart, T., Aszmann, O., Ludvik, B., Silberhumer, G. R., Prager, G., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1312 · Cited by 161
The Bone-Adipose Axis in Obesity and Weight Loss
Gómez-Ambrosi, J., Rodríguez, A., Catalán, V., & Frühbeck, G. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9548-1 · Cited by 160
“Moreover, OPN has been suggested to play a pivotal role linking obesity to insulin resistance development by promoting inflammation and the accumulation of macrophages in adipose tissue [ 62 ].”
BackgroundLee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 158
“All of the mice that have deletions in these genes exhibit improved insulin sensitivity, and this is frequently associated with a decrease in ATM infiltration (Kanda et al. 2006; Weisberg et al. 2006; Nomiyama et al. 2007; Chavey et al. 2009; Spite et al. 2011).”
Ito, A., Suganami, T., Yamauchi, A., Degawa-Yamauchi, M., Tanaka, M., Kouyama, R., Kobayashi, Y., Nitta, N., Yasuda, K., Hirata, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804220200 · Cited by 155
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
Clemente, N., Raineri, D., Cappellano, G., Boggio, E., Favero, F., Soluri, M. F., Dianzani, C., Comi, C., Dianzani, U., & Chiocchetti, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/7675437 · Cited by 156
“Moreover, OPN deficient mice are relatively protected against MS [83], RA [84], type 1 diabetes mellitus (T1DM) [85], autoimmune uveitis [86], autoimmune hepatitis [87, 88], intestinal bowel disease (IBD) [89], and Sjögren’s syndrome (SS) [90, 91].”
InfluentialBertola, A., Deveaux, V., Bonnafous, S., Rousseau, D., Anty, R., Wakkach, A., Dahman, M., Tordjman, J., Clément, K., McQuaid, S. E., et al. (2009) · Diabetes · doi:10.2337/db08-0400 · Cited by 150
“(9) have identified OPN as a link between adipose tissue inflammation and insulin resistance in a murine model of diet-induced obesity.”
BackgroundResultInfluentialGene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice
Aouadi, M., Tencerova, M., Vangala, P., Yawe, J. C., Nicoloro, S. M., Amano, S. U., Cohen, J. L., & Czech, M. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300492110 · Cited by 147
“The motivation for targeting TNF-α and OPN in epididymal ATMs in our studies was based on three major points: (i) both TNF-α and OPN mice are protected from obesity-induced insulin resistance (17, 22); (ii) the expression of these genes is high in AT from obese mice (Fig.”
BackgroundCharacterising metabolically healthy obesity in weight-discordant monozygotic twins
Naukkarinen, J., Heinonen, S., Hakkarainen, A., Lundbom, J., Vuolteenaho, K., Saarinen, L., Hautaniemi, S., Rodríguez, A., Frühbeck, G., Pajunen, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3066-y · Cited by 163
“In rodents, knocking out genes that are involved in the formation of the inflammatory response prevent the development of type 2 diabetes [47–49] and in humans, use of antiinflammatorymedications improves glycaemic control in type 2 diabetes and obesity [50].”
BackgroundMechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez-Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 141
“The expression levels of OPN are increased in obesity (160, 239) as well as in other pathophysiological processes including neoplastic transformation, progression of metastases, and promotion of cell survival (240).”
BackgroundOsteopontin in macrophage function
Rittling, S. R. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001839 · Cited by 141
Feng, B., Jiao, P., Nie, Y., Kim, T., Jun, D., van Rooijen, N., Yang, Z., & Xu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024358 · Cited by 140
“CCR2, osteopontin and CXCL14 [19–21].”
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 137
Adipose tissue immunity and cancer
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., & Frühbeck, G. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00275 · Cited by 148
“Recently, several studies have highlighted the expression of OPN in adipose tissue of both humans and mice and its involvement in obesity and obesityassociated T2D promoting inflammation and the accumulation of macrophages in adipose tissue (Gómez-Ambrosi et al., 2007; Nomiyama et al., 2007).”
BackgroundSears, D. D., Miles, P. D. G., Chapman, J., Ofrecio, J. M., Almazan, F., Thapar, D., & Miller, Y. I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007250 · Cited by 149
“Osteopontin (OPN) is a proinflammatory cytokine and monocyte chemotactic factor that also mediates obesity-induced insulin resistance [42].”
BackgroundRole of macrophage tissue infiltration in obesity and insulin resistance
Bourlier, V., & Bouloumié, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.05.001 · Cited by 161
“[35] Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, et al.”
BackgroundSingle-Cell Heterogeneity Analysis and CRISPR Screen Identify Key β-Cell-Specific Disease Genes
Fang, Z., Weng, C., Li, H., Tao, R., Mai, W., Liu, X., Lu, L., Lai, S., Duan, Q., Alvarez, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.043 · Cited by 128
“Particularly, IAPP forms islet amyloid, which is linked to cellular toxicity in T2D (Clark and Nilsson, 2004); SPP1 mediates the obesity-induced macrophage infiltration into adipose tissue and insulin resistance (Nomiyama et al., 2007); andCPE is important for proinsulin processing and its mutation leads to obesity an…”
Vascular biology of metabolic syndrome
Vykoukal, D., & Davies, M. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.003 · Cited by 127
Diabetes, Diabetic Complications, and Fracture Risk
Oei, L., Rivadeneira, F., Zillikens, M. C., & Oei, E. H. G. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0260-5 · Cited by 125
Hypoxia and the endocrine and signalling role of white adipose tissue
Trayhurn, P., Wang, B., & Wood, I. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802306602 · Cited by 127
The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging
Khan, S., Chan, Y. T., Revelo, X. S., & Winer, D. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00267 · Cited by 125
Foucault, A., Mathé, V., Lafont, R., Even, P., Dioh, W., Veillet, S., Tomé, D., Huneau, J., Hermier, D., & Quignard‐Boulangé, A. (2012) · Obesity · doi:10.1038/oby.2011.257 · Cited by 122
Agudo, J., Martín, M., Roca, C., Molas, M., Bura, S. A., Zimmer, A., Bosch, F., & Maldonado, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1894-6 · Cited by 128
“This agrees with the enhanced insulin sensitivity that was previously reported in obese mice with reduced WAT inflammation, such as Tnf-α (also known as Tnf) [40], CCL2 or Mcp-1 [41] and osteopontin mice [42].”
BackgroundFuentes, L., Rőszer, T., & Ricote, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/219583 · Cited by 119
“Osteopontin, which is produced by various cell types such as macrophages, hepatocytes and osteoclasts, promotes inflammation and macrophage accumulation in AT [104].”
BackgroundNeyestani, T. R., Nikooyeh, B., Majd, H. A., Shariátzadeh, N., Kalayi, A., Tayebinejad, N., Heravifard, S., Salekzamani, S., & Zahedirad, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3465 · Cited by 128
“Osteopontin (OPN), an extracellular matrix proinflammatory cytokine that induces chemotaxis, has been suggested as a link between bone and the immune system and a mediator of macrophage infiltration in adipose tissue and consequent insulin resistance in the murine model (3).”
The impact of senescence-associated T cells on immunosenescence and age-related disorders
Fukushima, Y., Minato, N., & Hattori, M. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0082-9 · Cited by 118
Role and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C.-H. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 114
Rowe, G. C., Raghuram, S., Jang, C., Nagy, J. A., Patten, I. S., Goyal, A., Chan, M. C., Liu, L. X., Jiang, A., Spokes, K. C., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303829 · Cited by 114
Rassart, É., Desmarais, F., Najyb, O., Bergeron, K., & Mounier, C. (2020) · Gene · doi:10.1016/j.gene.2020.144874 · Cited by 131
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seeman, I., Ghauharali-van der Vlugt, K., Overkleeft, H. S., Arbeeny, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 112
“OPN has been shown to amplify Ccl-2 mediated migration of macrophages [19].”
BackgroundA role for novel adipose tissue‐secreted factors in obesity‐related carcinogenesis
Fernández, B. C., Andrade, S., Carreira, M. C., Casanueva, F. F., & Crujeiras, A. B. (2016) · Obesity Reviews · doi:10.1111/obr.12377 · Cited by 114
Zeyda, M., Gollinger, K., Kriehuber, E., Kiefer, F. W., Neuhofer, A., & Stulnig, T. M. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.103 · Cited by 120
Staab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 122
RNAi-based therapeutic strategies for metabolic disease
Czech, M., Aouadi, M., & Tesz, G. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.57 · Cited by 118
“These mice show decreased macrophage infiltration into adipose tissue, which suggests that macrophage invasion into adipose tissue may also be a viable therapeutic target”
BackgroundKiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
“It has recently been suggested that genetic OPN deficiency and antibody-mediated neutralisation improve obesity-associated adipose tissue inflammation and glucose tolerance [19, 20].”
BackgroundResultInfluentialFestuccia, W. T., Pouliot, P., Bakan, I., Sabatini, D. M., & Laplante, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095432 · Cited by 103
“Reports published over the last decade have shown that obesity promotes systemic and low-grade inflammation in humans and rodents and that the inflammatory mediators secreted by activated macrophages play a crucial role in the development of insulin resistance[5,34–38].”
BackgroundVitamin D: Link between Osteoporosis, Obesity, and Diabetes?
Cândido, F. G., & Bressan, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046569 · Cited by 123
“On the other hand, increased osteopontin, even if moderate, stimulates the growth of adipose tissue and the development of chronic low-grade inflammation associated with obesity and insulin resistance [75,76].”
BackgroundAdipose Tissue Remodeling as Homeostatic Inflammation
Itoh, M., Suganami, T., Hachiya, R., & Ogawa, Y. (2011) · International Journal of Inflammation · doi:10.4061/2011/720926 · Cited by 120
“(Figure 2) [20–22].”
Kong, P., Gonzalez-Quesada, C., Li, N., Cavalera, M., Lee, D.-W., & Frangogiannis, N. G. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00006.2013 · Cited by 97
“Serum and adipose tissue osteopontin levels are markedly increased in obese individuals (13); osteopontin upregulation may mediate infiltration of fat tissue with proinflammatory macrophages, contributing to the development of metabolic dysfunction (33).”
BackgroundPleiotropic Effects of GIP on Islet Function Involve Osteopontin
Lyssenko, V., Eliasson, L., Kotova, O., Pilgaard, K., Wierup, N., Salehi, A., Wendt, A., Jonsson, A., De Marinis, Y. Z., Berglund, L. M., et al. (2011) · Diabetes · doi:10.2337/db10-1532 · Cited by 98
Link between GIP and osteopontin in adipose tissue and insulin resistance
Ahlqvist, E., Osmark, P., Kuulasmaa, T., Pilgaard, K., Omar, B., Brøns, C., Kotova, O., Zetterqvist, A. V., Stančáková, A., Jonsson, A., et al. (2013) · Diabetes · doi:10.2337/db12-0976 · Cited by 96
Osteopontin in Cardiovascular Diseases
Shirakawa, K., & Sano, M. (2021) · Biomolecules · doi:10.3390/biom11071047 · Cited by 105
“OPN has been reported to be increased in the circulating blood of obese diabetic and insulin-resistant patients [136,142] and to enhance visceral adipose inflammation, which results in insulin resistance [143,144].”
BackgroundIwaya, C., Nomiyama, T., Komatsu, S., Kawanami, T., Tsutsumi, Y., Hamaguchi, Y., Horikawa, T., Yoshinaga, Y., Yamashita, S., Tanaka, T., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00461 · Cited by 87
“Accordingly, inhibition and knockdown of inflammatory chemokines resulted in a reduction in blood glucose levels, as we previously reported using a knockout mouse model lacking the chemokinelike protein osteopontin (29).”
Self-citationOsteopontin is a key player for local adipose tissue macrophage proliferation in obesity
Tardelli, M., Zeyda, K., Moreno-Viedma, V., Wanko, B., Grün, N. G., Staffler, G., Zeyda, M., & Stulnig, T. M. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.09.003 · Cited by 90
Liu, L. F., Kodama, K., Wei, K., Tolentino, L. L., Choi, O., Engleman, E. G., Butte, A. J., & McLaughlin, T. (2015) · Diabetologia · doi:10.1007/s00125-015-3603-y · Cited by 108
“glucose intolerance and adipose tissue inflammation [9].”
BackgroundOsteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice
Chapman, J., Miles, P. D., Ofrecio, J. M., Neels, J. G., Yu, J. G., Resnik, J. L., Wilkes, J., Talukdar, S., Thapar, D., Johnson, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013959 · Cited by 87
“In contrast, chronic models of HFD feeding and obesity have increased levels of adipose tissue OPN protein [15,27,37].”
BackgroundInfluentialMargina, D. M., Ungurianu, A., Purdel, C. N., Nițulescu, G. M., Tsoukalas, D., Sarandi, E., Thanasoula, M., Burykina, T. I., Tekos, F., Djordjević, A. B., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111558 · Cited by 94
“Osteopontin, an ECM glycoprotein, excessively secreted by adipose tissue macrophages (Nomiyama et al., 2007) enhances adipose tissue inflammation and facilitates the onset of insulin resistance (Aouadi et al.”
Macrophages in epididymal adipose tissue secrete osteopontin to regulate bone homeostasis
Dai, B., Xu, J., Li, X., Huang, L., Hopkins, C., Wang, H., Yao, H., Mi, J., Zheng, L., Wang, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27683-w · Cited by 85
Patouraux, S., Bonnafous, S., Voican, C. S., Anty, R., Saint-Paul, M.-C., Rosenthal-Allieri, M.-A., Agostini, H., Njike, M., Barri-Ova, N., Naveau, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035612 · Cited by 86
“Similarly, OPN appears to play an important role in the occurrence of liver complications in a mouse model of non alcoholic fatty liver disease (NAFLD) [15,21,22,23].”
BackgroundKodama, K., Toda, K., Morinaga, S., Yamada, S., & Butte, A. J. (2015) · Diabetes · doi:10.2337/db14-0149 · Cited by 85
Zeyda, M., Gollinger, K., Todoric, J., Kiefer, F. W., Keck, M., Aszmann, O., Prager, G., Zlabinger, G. J., Petzelbauer, P., & Stulnig, T. M. (2011) · Endocrinology · doi:10.1210/en.2010-1328 · Cited by 85
Lancha, A., Rodríguez, A., Catalán, V., Becerril, S., Sáinz, N., Ramírez, B., Burrell, M. A., Salvador, J., Frühbeck, G., & Gómez-Ambrosi, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098398 · Cited by 84
“Our data show that lack of OPN partly prevented the increase of macrophages, CLS and Tnf expression caused by HFD in EWAT, extending previously reported data [8,45].”
ResultOsteopontin/SPP1: a potential mediator between immune cells and vascular calcification
Zhao, Y., Huang, Z., Gao, L., Ma, H., & Chang, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395596 · Cited by 104
Self-citationThe Roles of Adipose Tissue Macrophages in Human Disease
Liang, W., Qi, Y., Yi, H., Mao, C., Meng, Q., Wang, H., & Zheng, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908749 · Cited by 101
“Other molecules such as osteocalcin are also involved in the recruitment of ATMs and the progression of adipose tissue inflammation and may be targeted for intervention in metabolic-related diseases such as obesity (68).”
Background
Metadata
- Authors
- Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E. B., Jones, K. L., Kawamori, R., Cassis, L. A., Tschöp, M. H., & Bruemmer, D.
- Affiliations
- University of Kentucky (US)
- Juntendo University (JP)
- University of Cincinnati (US)
- Corresponding author
- Bruemmer, Dennis
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-10-01
- Volume
- 117
- Issue
- 10
- Pages
- 2877-2888
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1964510
- OpenAlex
- W2096574031
- Cited by
- 401
- References
- 56
- Citations by year
- 2026: 16 · 2025: 7 · 2024: 20 · 2023: 19 · 2022: 20 · 2021: 9 · 2020: 19 · 2019: 21 · 2018: 19 · 2017: 16 · 2016: 35 · 2015: 26 · 2014: 25 · 2013: 37 · 2012: 21
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- American Diabetes Association (0725313B, 1-06-RA-17, HL084611, 0435239N)
- American Heart Association
- University of Kentucky
- National Institutes of Health (1-06-RA-17, 0435239N, 0725313B, DK 59630)
- National Heart, Lung, and Blood Institute (HL084611, R01HL084611)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, U24DK059630)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- osteopontin, obesity, adipose tissue macrophages, insulin resistance, diet-induced obesity, macrophage infiltration, monocyte recruitment, macrophage motility, low-grade inflammation, high-fat diet, stromal vascular cells
- MeSH terms
- Adipose Tissue, Animals, Chemotaxis, Dietary Fats, Inflammation, Insulin Resistance, Macrophages, Mice, Mutant Strains, Obesity, Chemokine CCL2, Mice, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.